Iradimed (IRMD) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to -$56.5 million.
- Iradimed's Enterprise Value fell 929.04% to -$56.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$56.5 million, marking a year-over-year decrease of 929.04%. This contributed to the annual value of -$52.2 million for FY2024, which is 496.7% down from last year.
- Iradimed's Enterprise Value amounted to -$56.5 million in Q3 2025, which was down 929.04% from -$53.0 million recorded in Q2 2025.
- In the past 5 years, Iradimed's Enterprise Value ranged from a high of -$42.8 million in Q1 2023 and a low of -$62.5 million during Q4 2021
- For the 5-year period, Iradimed's Enterprise Value averaged around -$52.1 million, with its median value being -$52.2 million (2022).
- In the last 5 years, Iradimed's Enterprise Value crashed by 2024.57% in 2021 and then soared by 1603.53% in 2023.
- Quarter analysis of 5 years shows Iradimed's Enterprise Value stood at -$62.5 million in 2021, then increased by 7.26% to -$58.0 million in 2022, then rose by 14.15% to -$49.8 million in 2023, then fell by 4.97% to -$52.2 million in 2024, then dropped by 8.22% to -$56.5 million in 2025.
- Its Enterprise Value stands at -$56.5 million for Q3 2025, versus -$53.0 million for Q2 2025 and -$50.3 million for Q1 2025.